109 related articles for article (PubMed ID: 12903322)
1. Functional analysis of the pro-apoptotic factor Bax using hammerhead ribozymes.
Takeda H; Kawasaki H; Taira K
Nucleic Acids Symp Ser; 2000; (44):169-70. PubMed ID: 12903322
[TBL] [Abstract][Full Text] [Related]
2. Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer.
Dorai T; Olsson CA; Katz AE; Buttyan R
Prostate; 1997 Sep; 32(4):246-58. PubMed ID: 9288183
[TBL] [Abstract][Full Text] [Related]
3. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
Mitchell KO; Ricci MS; Miyashita T; Dicker DT; Jin Z; Reed JC; El-Deiry WS
Cancer Res; 2000 Nov; 60(22):6318-25. PubMed ID: 11103792
[TBL] [Abstract][Full Text] [Related]
4. Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2.
Thomas D; Yang H; Boffa DJ; Ding R; Sharma VK; Lagman M; Li B; Hering B; Mohanakumar T; Lakey J; Kapur S; Hancock WW; Suthanthiran M
Transplantation; 2002 Dec; 74(11):1489-96. PubMed ID: 12490780
[TBL] [Abstract][Full Text] [Related]
5. Bax-independent inhibition of apoptosis by Bcl-XL.
Cheng EH; Levine B; Boise LH; Thompson CB; Hardwick JM
Nature; 1996 Feb; 379(6565):554-6. PubMed ID: 8596636
[TBL] [Abstract][Full Text] [Related]
6. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
7. Characterization of pro-apoptotic gene Bak using hammerhead ribozymes.
Suyama E; Kawasaki H; Taira K
Nucleic Acids Res Suppl; 2001; (1):207-8. PubMed ID: 12836337
[TBL] [Abstract][Full Text] [Related]
8. Bax. The pro-apoptotic Bcl-2 family member, Bax.
Brady HJ; Gil-Gómez G
Int J Biochem Cell Biol; 1998 Jun; 30(6):647-50. PubMed ID: 9695020
[TBL] [Abstract][Full Text] [Related]
9. Pore formation domain of human pro-apoptotic Bax induces mammalian apoptosis as well as bacterial death without antagonizing anti-apoptotic factors.
Ishibashi Y; Nishimaki K; Asoh S; Nanbu-Wakao R; Yamada T; Ohta S
Biochem Biophys Res Commun; 1998 Feb; 243(2):609-16. PubMed ID: 9480856
[TBL] [Abstract][Full Text] [Related]
10. cpp32 messenger RNA neosynthesis is induced by fatal axotomy and is not regulated by athanatal Bcl-2 over-expression.
Guarin E; Seuret P; Nef S; de Bilbao F; Nef P; Dubois-Dauphin M
Neuroscience; 1999 May; 90(2):653-64. PubMed ID: 10215167
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and overexpression of bax protein and bax mRNA in smooth muscle cells within intimal hyperplasia of human radial arteries : analysis with arteriovenous fistulas used for hemodialysis.
Hayakawa Y; Takemura G; Misao J; Kanoh M; Ohno M; Ohashi H; Takatsu H; Ito H; Fukuda K; Fujiwara T; Minatoguchi S; Fujiwara H
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2066-77. PubMed ID: 10479647
[TBL] [Abstract][Full Text] [Related]
12. A recombinant defective adenoviral agent expressing anti-bcl-2 ribozyme promotes apoptosis of bcl-2-expressing human prostate cancer cells.
Dorai T; Perlman H; Walsh K; Shabsigh A; Goluboff ET; Olsson CA; Buttyan R
Int J Cancer; 1999 Sep; 82(6):846-52. PubMed ID: 10446452
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme.
Luzi E; Papucci L; Schiavone N; Donnini M; Lapucci A; Tempestini A; Witort E; Nicolin A; Capaccioli S
Cancer Gene Ther; 2003 Mar; 10(3):201-8. PubMed ID: 12637941
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.
Soufla G; Baritaki S; Sifakis S; Zafiropoulos A; Spandidos DA
Int J Biol Markers; 2005; 20(1):18-27. PubMed ID: 15832769
[TBL] [Abstract][Full Text] [Related]
15. Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax.
Shinoura N; Yoshida Y; Asai A; Kirino T; Hamada H
Oncogene; 1999 Oct; 18(41):5703-13. PubMed ID: 10523849
[TBL] [Abstract][Full Text] [Related]
16. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
Lindenboim L; Yuan J; Stein R
Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
[TBL] [Abstract][Full Text] [Related]
17. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
[TBL] [Abstract][Full Text] [Related]
18. Regulation of apoptosis by BH3 domains in a cell-free system.
Cosulich SC; Worrall V; Hedge PJ; Green S; Clarke PR
Curr Biol; 1997 Dec; 7(12):913-20. PubMed ID: 9382837
[TBL] [Abstract][Full Text] [Related]
19. Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms.
Minn AJ; Kettlun CS; Liang H; Kelekar A; Vander Heiden MG; Chang BS; Fesik SW; Fill M; Thompson CB
EMBO J; 1999 Feb; 18(3):632-43. PubMed ID: 9927423
[TBL] [Abstract][Full Text] [Related]
20. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
Schmitt E; Sané AT; Steyaert A; Cimoli G; Bertrand R
Biochem Cell Biol; 1997; 75(4):301-14. PubMed ID: 9493953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
